Q Fever in Young Children, Ghana
To the Editor: Recently, experts identifi ed Q fever, caused by the small, gram-negative bacterium Coxiella burnetii, as an important underdiagnosed childhood disease (1) . Studies on Q fever in children <5 years of age are scarce, especially with respect to sub-Saharan Africa. The only available study from Niger reports a seroprevalence of 9.6% (2) . Throughout Africa, prevalence of Q fever in adults shows considerable variability and is highest in countries with prominent stockbreeding (3) .
Clinical manifestations of Q fever in children are similar to those of malaria (1, 4) . In malaria-endemic areas, most fevers are attributed to Plasmodium falciparum infection and presumptively treated with expensive combination therapies (5) . In this context, other neglected fever-causing pathogens need to be given appropriate consideration.
We studied the prevalence of Q fever antibodies in 219 randomly selected children living in 9 rural villages of the Ashanti region, Ghana. Plasma was obtained by venous puncture from 2-year-old children after they had participated in a malaria control study and had been clinically monitored for 21 months. Clinical, parasitologic, socioeconomic, and Global Positioning System information was recorded as described elsewhere (6, 7) . In addition, 158 healthy adult volunteers from the same area were included. Plasma was stored at -20°C until microimmunofl uorescence assays (IFA) (Coxiella burnetii I+II, Vircell SL Microbiologists, Granada, Spain) were performed according to manufacturer's instructions. To identify all children with Q fever titers, we regarded the following as positive fl uorescence reactions to plasma dilutions: >1:64 for phase II immunoglobulin (Ig) G and >1:24 for phase II IgM with sensitivity (specifi city) of 97.2% (100%) and . On the day of the serosurvey 71 (32.4%) of 219 children had fever (measured body temperature >38°C or reported fever within the previous 48 hours). Test outcome did not appear to be infl uenced by P. falciparum infection, since 4 of 37 IgG-positive children (23 of 182 IgG-negative children) had clinical malaria, 11/37 (62/182) had asymptomatic parasitemia, and 6/37 (38/182) had fever without parasitemia, and there were no signifi cant differences between groups. The frequency of prior malaria episodes also did not infl uence antibody response. Three aparasitemic children had positive phase II IgM titers (24, 96, and 1,536; phase II IgG 64, 64, and 4,096, respectively). The child with the high IgM and IgG titers was clinically ill with nonsevere C. burnetii pneumonia. This child was among 10 (27%) of 37 phase II IgG-positive children with detectable anti-C. burnetii phase I antibodies. Of all sociodemographic characteristics under consideration, only maternal illiteracy was associated with positive phase II IgG testing (RR 2.1, 95% confi dence interval 1.0-4.2, p<0.05).
A considerable proportion of Ghanaian children had anti-C. burnetii antibodies, which indicates that Q fever might be a common event in Table and should not be divided into sections. All letters should contain material not previously published and include a word count.
this age group. Antibodies were more frequently detected in children than in adults. In adults, Q fever IgG antibodies reach a maximum 4-8 weeks after onset of symptoms and gradually decrease over months to fi nally fall below the detection limit (8) .
A long period since infection is less likely in young children, which could result in higher seropositivity. Children, especially those of illiterate mothers, could also be more frequently exposed to the pathogen. Consumption of unpasteurized dairy products can result in infection or seroconversion without clinical disease (9) . However, because consumption of raw milk in the Ashanti region is regarded as being uncommon by local health authorities, we consider dairy products an unlikely source of the disease. Although participants were intensively exposed to P. falciparum, which causes polyclonal Bcell stimulation, malaria episodes and parasitemia with and without symptoms at time of the serosurvey did not infl uence testing (10) . This fi nding is important because commercially available test kits have only been evaluated in Europeans not exposed to parasites. We cannot completely rule out the possibility that other infectious agents, which are either only prevalent or more prevalent in African populations, could have resulted in false-positive results. Nevertheless, the test method we used and existing data on cross-reactions weaken this hypothesis (8) .
We conclude that children in rural sub-Saharan Africa become exposed to C. burnetii early in life and that Q fever, which is clinically indistinguishable from malaria, may develop in an unknown proportion of them. The incidence of Q fever in relation to malaria, the route of infection, and appropriate serologic cutoffs for sub-Saharan Africa must be defi ned further. Currently, a prospective diagnostic study is investigating neglected infections, including human Q fever, as a cause of illness in Ghanaian children. 
Early Diagnosis of Disseminated Mycobacterium genavense Infection
To the Editor: Nontuberculous mycobacteria are environmental organisms that cause life-threatening diseases, particularly in immunocompromised hosts. They are increasingly recognized for causing problems in the management of solid-organ transplant recipients, due to improved diagnostic methods as well as increasing numbers and life expectancy of these patients (1). The slow-growing Mycobacterium genavense is a ubiquitous nontuberculous mycobacterium; it is reportedly isolated from tap water, pets, and the gastrointestinal tract of healthy humans (1,2). It was fi rst recognized as a human pathogen in a patient with AIDS but has not yet been found in heart transplant recipients (3). We report early diagnosis of disseminated M. genavense infection in a heart transplant recipient.
A 37-year-old man was hospitalized in September 2001 for abdominal pain, sweats, and weight loss; he had received a heart transplant 3 years earlier. Immunosuppressive treatment, which began immediately after transplantation, consisted of tacrolimus (5 mg) and mycophenolate mofetil (2 g) daily; concurrent steroid therapy was tapered off over the next 6 months. A computed tomographic (CT) scan showed numerous large lymph nodes in his abdomen (Figure) . Endoscopic examinations showed diffuse infl ammation of the mucosa of the duodenum, ileum, and colon. Multiple biopsy samples were submitted for histologic analysis, culture, and molecular biological analysis. Immediate 16S rRNA gene amplifi cation that used universal primers (4) and sequencing of samples taken directly from the biopsy material led to the identifi cation of M. genavense. A 475-bp fragment was sequenced, and 99% homology with the gene of type strain ATCC 51234 (GenBank accession no. X60070) was found. PCR results were positive for 2 of the 4 samples tested. The molecular identifi cation was compatible with the subsequent histologic fi nding of profound macrophage infi ltration without granuloma and the presence of Ziehl-Neelsen-positive bacilli. Five weeks later, the molecular diagnosis was confi rmed by blood cultures and cultures of the intestinal mucosa samples (Inno-LiPA Mycobacteria test, version 2, Innogenetics, Courtaboeuf, France). The direct molecular diagnosis of M. genavense enabled immediate treatment of the patient with the combination of moxifl oxacin, ethambutol, clarithromycin, and amikacin; mycophenolate mofetil was discontinued. Clofazimine was added to the treatment regimen 3 months later, when a control CT scan showed that some of the enlarged mesenteric lymph nodes had increased further. After 5 months, the clinical signs resolved, and after 9 months, the lymph nodes were substantially smaller. CT scan results were within normal limits after 12 months of treatment; only ethambutol and clarithromycin were continued for an additional 6 months. There was no sign of M. genavense infection relapse 3 years after the diagnosis had been made.
Nontuberculous mycobacteria in persons who have received heart or other solid-organ transplants remain a rare cause of late infectious complications and occur ≈3.5 years after transplantation (1, 4) . In the subgroup of heart transplant recipients, skin disease is the most common clinical manifestation, followed by pulmonary and disseminated disease; M. kansasii, M. avium complex, and M. haemophilum infections are most frequently encountered (1, 5) .
M. genavense causes up to 12.8% of all nontuberculous mycobacteria infections in AIDS patients; these infections are clinically similar to those caused by the M. avium complex (1, 6) .
